Shawn Patrick O'Brien

Shawn Patrick O'Brien is an accomplished executive with extensive experience in the biopharmaceutical sector. Currently serving as the Chief Executive Officer and Managing Director of Mayne Pharma since October 2022, O'Brien also holds the position of Chairman of the Board at SFA Therapeutics and Key BioPharma Partners. With a background that includes leadership roles such as CEO of Genomind and President & CEO of Cipher Pharmaceuticals Inc., O'Brien has been instrumental in advancing drug development and commercialization strategies. Additionally, O'Brien contributes to various organizations as an advisory board member, including the Greater Philadelphia Life Sciences Congress and Schoemaker Classic for Melmark. O'Brien's educational background includes a Bachelor of Science in Microbiology and Immunology from Western University.